Karen Wagner, a psychiatry professor at the University of Texas Medical Branch in Galveston, seems to sound a repetitive theme in her work: Accept undisclosed money from drug companies; put your name on articles substantively ghostwritten for drug companies; and just generally over many years demonstrate the sort of behavior that gets you … named president of the American Academy of Child and Adolescent Psychiatry.

Rewards in this field, after all, go to people able to increase the probability that drug firms – eager, in the latest case involving Wagner, to rain anti-depressants upon the heads of our teeniest tots – will get FDA approval for their products.

Does the pill do anything a placebo doesn’t… ? Might it have dire side effects… ?

Erfahrt, wie sich die Pharmakonzerne rächen,
von deren Huld ihr euch gewandt!


UD‘s friend Barney suggests some ways out.


Oh – and speaking of kiddies and the makers of fun adorable stuff for them to play with, like Risperdal blocks – a new movie about that drug is coming out, and UD is way excited at the possibility that it will star one of the most… intriguing characters we’ve met on this blog: Harvard’s Joseph Biederman.

Trackback URL for this post:

3 Responses to “Wagnerian Leitmotif”

  1. Derek Says:

    There is no University of Texas Galveston.

  2. Margaret Soltan Says:

    Derek: I know. I abbreviated the name out of laziness. I’ll fix.

  3. Derek Says:

    No worries — knowing the ins and outs of UT System nomenclature ought not to be high on anyone’s list.

Comment on this Entry

Latest UD posts at IHE